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SUMMARY 
This study describes effects of  ACTH1-24 and fl-endorphin on brain polyphos- 
phoinositide metabolism in vitro. The interconversion of  these polyanionic phospho- 
lipids was studied by incubation of a lysed synaptosomal fraction with [?-a2P]ATP. Of  
the membrane phospholipids only PA, DPI  and TPI  became labeled. The reference 
peptide ACTH1-24 stimulated the formation of TPI  and inhibited the production of  
PA. For effects on TPI  formation both the sequences ACTHs-7 and ACTHlo-16 were 
needed. Effects on PA formation required the sequences ACTH7-10 and ACTHlo-16. 
The basic amino acids in ACTHlo-16 seemed to be of  crucial importance 
for the peptide effects. A stimulatory effect on DPI was visible when A C T H  
was shortened from the N-terminus, and the essential information was in 
ACTHT-lo. fl-endorphin inhibited PA formation and this effect was abolished by C- 
terminal shortening to ?-endorphin. Other fragments of  the C-terminus of fl-LPH, 
including the enkephalins, were ineffective. I t  is concluded that the structure-activity 
relationship on TPI /PA formation correlates with a similar relationship obtained on 
excessive grooming behavior in vivo. A possible correlation between the effects on 
polyPI metabolism and opiate-like effects, and effects on extinction of active avoidance 
behavior in vivo is discussed. 
* To whom correspondence should be sent at: Division of Molecular Neurobiology, Institute of 
Molecular Biology and Rudolf Magnus Institute for Pharmacology, University of Utrecht, Padualaan 
8, 3508 TB Utrecht, The Netherlands. 
0006-8993/81/00(O-0000/$ 02.50 © Elsevier/North-Holland Biomedical Press 
316 
INTRODUCTION 
Peptides, which are structurally related to ACTH, MSH and fl-LPH, are 
important modulators of both animal and human behavior 5. Among the reported 
behavioral effects are those on avoidance behavioda, 15 and on induction of excessive 
grooming behavior in the ratl°,lL These effects are a consequence of a direct action of 
these peptides on specific areas of the central nervous system a,~. In in vitro studies, 
effects of ACTH-like peptides on brain membrane processes have been obtained. In 
these membranes, structure-dependent effects on adenylate-cyclase ~5 and protein 
phosphorylation 37 were found that correlated with the structure-activity relationship 
observed for the induction of excessive grooming behavior in vivo 12,1~. In addition, 
ACTHI-za was found to affect the metabolism of a special class of brain membrane 
phospholipids, the polyphosphoinositidesZ0, 21 and a causal relationship between 
polyPI metabolism and membrane phosphorylation was demonstrated z0. Adrenal 
DPI and TPI were also affected, both after in vivo and in vitro administration of 
ACTH6-S. 
In the present study fragments of ACTH and of C-terminal fl-LPH were tested 
for their capacity to modulate the polyPI metabolism. The structure-activity relation- 
ship is compared to other brain-ACTH interactions (active avoidance conditioning, 
excessive grooming, counteraction of morphine-induced analgesia, opiate receptor 
affinity, adenylatecyclase and protein phosphorylation). 
MATERIALS AND METHODS 
Animals and brain dissection 
Male rats (150 g) of  an inbred Wistar strain were used (TNO, Zeist, The 
Netherlands). After decapitation the brain was rapidly removed. All subsequent 
operations were performed at 0 4  °C. Limbic structures (hippocampus, septum, 
basal ganglia, pyriform cortex, diencephalon, mesencephalon) were dissected as 
described beforeL 
Subcellular fractionation 
The preparation of the enzyme fraction was performed essentially as described 
previously 21. The dissected material from one rat brain (0.3 g) was homogenized in 3 
ml homogenization medium (0.32 M sucrose, 1 mM EDTA, 10 mM Tris-HC1, pH 
7.4). The crude mitochondrial/synaptosomal pellet (P2) was obtained and subjected to 
osmotic lysis: the P2 was suspended in 10 vols. aqua bidest and stirred for 10 min at 4 
°C. This suspension was centrifuged for 20 min at 10,000 g and the supernatant of the 
lysed P2 (further referred to as membrane-cytosol fraction) taken as the enzyme 
fraction. 
Phosphorylation assay 
Endogenous lipid phosphorylating activity was assayed as described previous- 
ly 21. Briefly, the incubation was performed under the following conditions: 7.5 #M 
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ATP, 3/~Ci [7-a2P]ATP (approx. 3000 Ci/mmol, Amersham, U.K.), 50 mM sodium 
acetate, 10 mM magnesium acetate, pH 6.5 in a final volume of 25/A, containing 10-15 
#g protein) was preincubated for 5 min and the incubation started by the addition of 
the ATP. Aliquots of the incubation buffer (5/zl) plus or minus peptides were added 15 
s prior to the ATP. The incubations were terminated after 10 s by the addition of 2 ml 
ice-cold chloroform/methanol/13 N HC1 (200:100:0.75 by volume see ref. 21). Protein 
determination was according to Lowry et al. ~5. 
Preparation of  lipid/B-50 kinase fraction, and lipid kinase assay 
The ACTH-sensitive B-50 protein kinase was purified according to Zwiers et 
al.Z8, ag. In short, a crude synaptosomal plasma membrane fraction was prepared from 
rat brain. The membrane-bound kinase activity was solubilized with 0.5 ~o Triton-X- 
100 with 75 mM KCI in 6 mM Tris, 0.1 mM dithiothreitol (pH 8.1)and the solubilized 
proteins separated by DEAE cellulose chromatography. The proteins were eluted with 
a salt gradient in 10 mM Tris, 1 mM CaCI2, 0.1 mM dithiothreitol, pH 7.4. The 
fractions containing the peak of the ACTH-sensitive lipid kinase activity (eluting at 
170-205 mM salt), were collected and pre-incubated for 5 min at 30 °C in the presence 
of exogenous DPI (40 #M), followed by incubation with [?-32P]ATP (7.5/~M) for 15 
min. The addition of peptide was 15 s before ATP was added. 
Lipid extraction and thin layer chromatography 
After termination of the phosphorylation reaction, carrier polyPI (10/zg P) was 
added and extraction of the labeled phospholipids was performed as described 21. 
Briefly, by adding 0.375 ml 0.6 N HCI a biphasic system was obtained. The upper 
phase was removed and the lower phase washed two times with chloroform/methanol/ 
0.6 N HC1 (3:48:47 by volume). The resulting lower phase containing the polyphos- 
phoinositides was dried under N2 and re-dissolved in chloroform/methanol/water 
(75:25:2 by volume). Separation of labeled phospholipids was performed by one- 
dimensional High Performance Thin Layer Chromatography (HPTLC Merck; layer 
thickness 25/zm). The plates were impregnated with potassium oxalate and activated 
for 15 min at 110 °C zl. The solvent was chloroform/acetone/methanol/glacial acetic 
acid/water (40:15:13:12:8 by volume). The lipids were visualized with iodine vapour 
and 32P-labeled spots were detected by autoradiography on Kodak Royal X-Omat 
film (10-20 h). The spots were scraped from the plates and radioactivity was 
determined by liquid scintillation counting 21. 
Stat&tics 
Differences between groups were tested with the Student t-test z6, and assigned to 
be significant for P < 0.05, two-tailed. 
Materials 
The following synthetic peptides were used: ACTH1-24, ACTHl-16, ACTHl-13, 
ACTHI-lo, (D-PheT)ACTHI-10, ACTHxl-24, ACTHs-la, ACTHT-16, ACTH4-10, (D- 
PheT)ACTH4-1o, (Met(O)4,D-Lysa,Pheg)ACTH4-9, (Met(O)4,D-LysS,Pheg,D-Lys 11) 
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TABLE I 
A CTH-fragments andpolyphosphoinositide metabolism 
A membrane-cytosol fraction was prepared as described (see Methods). The membrane samples were 
preincubated for 5 rain at 30 °C and the incubation was started by the addition of ATP plus [7-a2P]ATP. 
Buffer solution plus or minus peptide (100 #M) was added 15 s before ATP. Incubation time was 10 s. 
The results (mean ± S.E.M. ; n = 4) are expressed as fmol P incorporated per #g protein. Numbers 
between parentheses refer to the percentage difference (P < 0.05) to control incubations. 
A CTH sequence Incorporation (fmol Pper t~g protein) 
TPI DP1 PA 
Control 1.02 4- 0.11 2.40 ± 0.15 5.44 ± 0.24 
(1-24) 2.63 -- 0.13 (+158) 2.05 ± 0.16 2.46 i 0.21 (--55) 
(1-16) 1.54 ± 0.04 (+51) 2.30 4- 0.17 3.12 :E 0.17 (~43) 
(1-13) 1.23 ± 0.03 (+21) 2.38 d: 0.18 4.17 ± 0.23 (--23) 
(Ac-Ser 1) (1-13) NH2 1.15 4- 0.02 2.34 4. 0.15 5.20 4. 0.25 
(1-10) 1.07 4- 0.11 2.46 4. 0.20 4.97 4. 0.30 
(o-Phe 7) (1-10) 0.70 4- 0.06 (--31) 3.63 4, 0.10 (+51) 5.40 4. 0.23 
(11-24) 0.90 4- 0.09 2.78 4- 0.19 5.98 4. 0.53 
(1-10)+ (11-24) 1.01 4. 0.08 2.79 4. 0.20 6.08 ± 0.44 
(5-18) 2.37 4. 0.17 (+132) 5.54 4. 0.49 (+130) 2.76 -4- 0.17 ( 4 9 )  
(7-16) 0.87 4. 0.10 4.23 4- 0.09 (+76) 2.20 4. 0.11 (--60) 
(5-14) 0.48 4- 0.05 (--53) 3.19 4, 0.13 (+33) 5.56 4. 0.36 
(4-10) 1.12 4, 0.07 2.87 4. 0.06 (+19) 5.88 4. 0.09 
(D-Phe 7) (4-10) 0.97 4. 0.04 2.96 4, 0.10 (+23) 6.04 4. 0.26 
ACTH4-16, fl-LPH61-91, fl-LPH61-77, fl-LPH62-77, fl-LPH-61-76, fl-LPH6e-76, (Met65)fl - 
LPH61-65, (Leu65)fl-LPH61-65, a -MSH.  They were obtained f rom Organon Int. B.V. 
(Oss, The Netherlands).  
RESULTS 
Peptide-modulated po lyPI  metabolism: structure-activity relationship 
In a series o f  experiments the effects o f  A C T H  fragments  on polyPI  metabol ism 
was studied. A membrane-cytosol  fract ion was obtained as described (see Methods)  
and incubated for 10 s in the presence o f  peptide and [y-Z2]ATP. Unde r  the condit ions 
ACT H 1-24 
His "Phe.Arg. Try. Gly. Lys.Pro. Val. Gly. Lys. Lys. Arg,Arg. Pro, Val .Lys.Val .Tyr .Pro .OH 
(24) 
Glu (5) 
M e t  (1) 
~;ser Tyr. Ser .NH 2 
. Asn.Ala. lie . Val . Lys. Asn.Ala, His. Lys, Lys .Gly. Glu. O H 
Lys (91) 
Phe (78) 
/~- endorphin I'eu (77) (61) 
"Thr.val ,LeulPro .Thr Gin .Ser .Lys.Glu .Ser.Thr.Met.Phe.Gly .Gly .Tyr .NH 2 
Fig. 1. Amino acid sequence of ACTHI-~4 and fl-endorphin (flLPH6x-90. 
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used, only TPI, DPI  and PA became labeled 21. At the dose level tested (100/~M) a 
structure-activity relationship could be established for the A C T H  fragments (Table I;  
see Fig. 1 for the amino acid sequence of ACTHI-z4 and fl-endorphin). ACTH1-24 
stimulated the formation of TPI  and at the same time inhibited the formation of PA 
(Table I and ref. 10). Identical effects were obtained with some of  the other N-terminal 
fragments of  ACTH.  The order of  decreasing potency was ACTH1-24 > ACTHs- l s  > 
ACTHl-16 > ACTHI-lz .  Interestingly, shortening the A C T H  sequence from the N- 
terminal side dissociated the effects on TPI  f rom those on PA, since ACTHT-16 had no 
effect on TPI  formation but fully inhibited PA production: A C T H  fragments that were 
shortened at the N-terminal side exhibited a reduced effect on TPI. Instead the 
formation of DPI  was stimulated by these peptides (in order of  decreasing potency on 
DPI  formation): ACTHs- t s  > ACTH7-16 > ACTHs-14 (Table I). A stimulation of  
DPI  formation was also found for (D-Phe 7) A C T H  4-10, A C T H  4-10, ACTHs-14 and (D- 
PheT)ACTHI-10. ACTHI-~0 and ACTHll-24 and their combination were completely 
inactive in every respect. 
A possible correlation between effects on polyPI metabolism and conditioned 
avoidance behavior was explored by testing some A C T H  analogues which are 
extremely potent in inhibiting extinction of a conditioned avoidance response but fail 
to induce excessive grooming is. As shown in Table II, the potentiated sequences (4-9) 
and (4-16) did not affect TPI  or PA formation, but both peptides stimulated the 
formation of DPI. 
We then tested the effects of  C-terminal fragments of  fl-LPH, some of which 
also display profound influences on extinction of conditioned avoidance behavior and 
on induction of excessive grooming behavior 12. fl-LPH61-91 had no effect on DPI  or 
TPI formation but inhibited the formation of PA in a dose-dependent manner (Fig. 2) 
As shown in Table III ,  fragments of  fl-endorphin, including the enkephalins were 
without any detectable effect. 
TABLE II 
A CTH-analogs andpolyphosphoinositide metabolism 
Incubations were performed as described in the legend to Table I. Peptides (100/~M) were added 15 s 
before ATP. The results (mean 4- S.E.M.) are expressed in fmol P per/~g protein. Numbers between 
parentheses refer to the percentage difference (P < 0.05) to control incubations. 
Peptide Incorporation (fmol per tLg protein) 
TP1 DPI PA 
Control 0.99 =[= 0.10 2.38 ± 0.11 5.46 -4- 0.20 
ACTHI-sa 2.75 + 0.18 (+178) 2.15 =[= 0.16 2.68 -4- 0.19 (--51) 
ACTH4-9* 0.84 ± 0.03 2.74 -4- 0.05 (+15) 5.11 -l- 0.11 
ACTH4-1e** 0.89 -4- 0.05 2.85 ± 0.11 (+20) 5.52 -4- 0.46 
* (Met(O) 4, D-Lys a, Phe 9) ACTH4-9, * * (Met(O) 4, D-Lys n) ACTH4-1e. 
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Fig. 2. Dose response relation of ACTHI-z4 and fl-endorphin on polyphosphoinositide metabolism 
in the membrane-cytosol fraction. Incubations were performed as described in the legend to Table 1. 
Peptides (0.01-100/~M) were added 15 s before ATP. The results (mean ± S.E.M., n = 6) are 
expressed as percentage of control incubations. ©, ACTH;O, fl-endorphin. 
Effects of  ACTHz-z4 and fl-endorphin on polyPI metabolism in a partially purified 
enzyme preparation 
The possibi l i ty  tha t  A C T H  and  f l -endorphin act on the same membrane  
components ,  was s tudied by  compar ing  the effects on the po lyPI  metabol i sm in a 
par t ia l ly  purified enzyme prepara t ion .  This p repa ra t ion  conta ined  ACTH-sens i t ive  
pro te in  kinase activity20, 3s and  l ipid kinase activity20,zL I t  appea red  (Table IV) tha t  
bo th  ACTH1-24 and  f l -endorphin  dose-dependent ly  inhibi ted  the fo rma t ion  o f  PA. 
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TABLE III 
Fragments of flLPHel-gt ( fl-endorphin) and polyphosphoinositide metabolism 
Incubations were performed as described in the legend to Table I. Peptides (100 ~M) were added 15 s 
before ATP. The results (mean 4- S.E.M. ; n = 4) are expressed in fmol per/~g protein. Numbers 
between parentheses refer to the percentage difference (P < 0.05) to control incubations. 
fl-LPH sequence Incorporation (fmol P per I~g protein) 
TPI DPI PA 
Control 
(61-91) (fl-endorphin) 
(61-77) (~,-endorphin) 
(62-77) (des-Tyr-~,-endorphin) 
(61-76) (a-endorphin) 
(62-76) (des-Tyr-a-endorphin) 
(61-65) (Met-enkephalin) 
(61-65) (Leu 65) (Leu-enkephalin) 
0.99 ± 0.10 2.38 4- 0.11 5.46 4- 0.20 
0.97 ± 0.05 2.48 4- 0.14 1.97 4- 0.22 (--64) 
0.82 4- 0.07 2.35 ± 0.09 5.41 4- 0.44 
0.94 i 0.03 2.55 4- 0.01 5.03 4- 0.27 
0.96 t :  0.03 2.09 4- 0.08 5.11 4- 0.11 
1.15 i 0.10 2.41 4- 0.10 5.27 ± 0.31 
0.97 4- 0.01 2.61 4- 0.12 5.31 4- 0.20 
0.98 4- 0.04 2.55 ± 0.14 4.99 4- 0.22 
A C T H  marked ly  s t imula ted  the  p roduc t ion  o f  TPI  whereas f l -endorphin had  only 
m i n o r  influence on this po lyphosphoinos i t ide .  
DISCUSSION 
The present  s tudy describes effects o f  A C T H ,  f l -endorphin and congeners  on the 
me tabo l i sm of  the po lyphospho inos i t ides  in ra t  brain.  A l though  the pept ide  effects 
m a y  seem complex,  a logical  re la t ionship  exists between them, in view o f  the close 
re la t ion  tha t  exists between the affected lipids.  As  shown in Fig.  3, PI, D P I  and  TPI  are  
r ap id ly  in terconver ted  by  phospho ry l a t i on  and  dephosphory la t ion  (react ions 1 and 
2) e6. The ionic  head  group,  con ta in ing  the inosi tol  r ing and  one, two or  three 
phospha te  groups,  can be cleaved by  a phospho l ipase -C type reac t ion  (react ion 3). The  
result ing 1,2-diacylglycerol  is rap id ly  phosphory l a t ed  to  P A  (react ion 4). In  experi-  
TABLE IV 
Effect of ACTHI-z4 and fl-endorphin on polyPl metabolism in a partially purified lipid kinase preparation 
The purification of the lipid kinase was as described previously (see Methods). The results (mean 4- 
S.E.M. ; n = 4) are expressed as fmol per/~g protein per min. Numbers between parentheses refer to 
the percentage difference (P < 0.05) to control incubations. 
Treatment Incorporation (fmol P per i~g DEAE protein/min) 
TPI PA 
No addition 234 ± 6 
ACTHI-s4 (10#M) 276 ± 8 (+18) 
ACTH1-24 (50/~M) 397 ± 7 (+70) 
fl-endorphin (10/~M) 237 ± 20 
fl-endorphin (50#M) 300 d_ 6 (+28) 
346 4- 18 
189 4- 9 (--55) 
72 4- 8 (--80) 
228 i 16 (--34) 
55 ± 6 (--84) 
322 
(1)PI kinase.. 
P I  : 
~ ) 
DPI _-(2)DPI kinase.. TPI 
(3)~P.oly) PI phosphodiesterase I (3) 
1,2-diacylglycerol 
t4) 1,2-diacylglycerol kinase 
PA 
Fig. 3. Interconversion of the polyphosphoinositides. 
ments with neurotransmitterst, 2 and the Ca z+ ionophore A2318716 it has been found 
that a decreased formation of DPI and TPI is correlated to an increased production of  
PA. Therefore, and in view of the inverse relation between PA-formation and 
TPI-DPI  formation that was found in the present study, the production of PA may be 
a manifestation of the breakdown of (poly)PI. With regard to the mechanism of  action 
of ACTH, it has been demonstrated that the effect of the peptide is only evident in 
conditions where active phosphorylation can be monitored21,2L ACTH exclusively 
acts on the lipid kinase(s) involved (reactions 1,2,4) thus leaving the phosphomono- 
and diesterase activity unaffected. 
Structural requirements needed for stimulation of DPI and TPI formation 
The presently reported structure-activity data will be discussed in terms of 
multiple affinity sites within the peptide structure 5 (see Figs. 1 and 3). With regard to 
the PI kinase, both the sequences (4-10) and (7-16) stimulated DPI formation. 
Therefore, we assume that this property may have originated from the common 
sequence (7-10). With respect to the DPI kinase (reaction 2), the sequences (7-16) and 
(5-14) were inactive, whereas (5-18), (1-16) and (1-13) stimulated TPI formation. 
Therefore, it may be that both the sequence (5-7) and the basic amino acids at the C- 
terminus (Lys 11 in (1-13) or Lys 15, Lys 16, Arg iv, Arg 18 in (1-16) or (1-18)) are a 
prerequisite for ACTH-stimulation of  the DPI kinase. The PI- and the DPI-kinase are 
different enzymes 26. The accumulation of DPI after incubation with ACTHT-16 
indicates that this peptide contains the structural requirements to stimulate PI kinase 
but not DPI kinase. N-terminal elongation to ACTHs-16 then adds information that is 
essential for the stimulation of the DPI kinase (i.e. the sequence 5-7). This may 
explain that TPI accumulates after incubation with ACTHs-18 and ACTHl-16. 
Structural requirements needed for inhibition of PA formation 
As discussed above, the formation of DPI/TPI may take place at the cost of PA. 
However, some fragments stimulated DPI formation without a concomitant decrease 
in PA formation (e.g. ACTH4-10, ACTHs-14). This suggests that effects on PA 
formation are a direct result of inhibition of reaction 4, probably accompanied by a 
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stimulatory effect on reaction 1 (and 2). As was also argued for the structure-activity 
relationship with respect to DPI kinase activation, the inhibition of 1,2-diacylglycerol 
kinase (reaction 4) requires both the presence of the (7-10) sequence and of basic 
amino acids at the C-terminus. The fragments (1-10), (11-24), (5-14) and (4-10) were 
inactive, whereas (7-16), (5-18), (1-16) and (1-13) were active (Table I). The 
structural requirements needed for inhibition of PA formation appear to be in the 
sequence (7-16). As sequences containing different amounts of basic amino acids in 
their C-terminal region have different potency in effects on TPI and PA, these basic 
amino acids seem of crucial importance for the peptide-lipid kinase interaction. 
Interestingly, fl-endorphin also had an inhibitory effect on the formation of PA 
(Table III). A relationship between the effects of ACTH1-24 and fl-endorphin is 
suggested by the finding that both peptides were similarly effective in this inhibition of 
PA production in a purified protein-lipid kinase preparation (Fig. 2; refs. 20 and 22). 
fl-endorphin also had some effect on TPI formation but in comparison to ACTH the 
effect was small. C-terminal shortening to y-endorphin (fl-LPH61-77) abolished the 
effect on PA. None of the other endorphin fragments tested, had any effect on the 
polyPI metabolism. This may indicate that the basic properties of the endorphin 
fragment fl-LPHvs-al are responsible for the effects of fl-LPH61-91; this C-terminal 
fragment shows some resemblance to ACTHs-16 (Fig. 1): (1) both peptides contain a 
Lys-doublet at their C-terminus, (2) a third Lys-residue is present which is separated 
from the doublet by three amino acids (i.e. Lys s4 in fl-endorphin and Lys 11 in ACTH) 
and (3) both peptides contain the combination Phe-basic amino acid residue at their 
N-terminus. 
As the conversion of PI to PA may underly calcium-gating in the membrane 26, 
the presently reported data on the effect of fl-endorphin are in support of the recent 
demonstration that fl-endorphin can inhibit the influx of calcium into synaptosomes, 
leading to a reduced release of neurotransmitters 17. 
Correlation between peptide effects on polyPl metabolism and those obtained on other 
parameters 
Also in other CNS effects of ACTH the affinity sites in ACTH4-10 and in 
ACTH10-1a coded for activity, i.e. delay of extinction of avoidance behavior4, 5, 
binding to opiate receptors al, counteraction of morphine-induced analgesia 11, induc- 
tion of excessive grooming behavior 10, modulation of cAMP production aS, and of 
protein synthesis in a cell-free system 29. 
If we now consider these ACTH-CNS structure-activity relationships obtained 
with ACTH, a great similarity in structural requirements appears to exist for the effects 
on TPI- and PA-formation, and those on the inhibition of the phosphorylation of B-50 
protein (active are (1-24), (5-18), (1-16), (1-13) aT. A relation was found between 
protein phosphorylation and TPI formation 20 and nearly all peptides that inhibited B- 
50 protein phosphorylation induced excessive groomingla, 40. The mechanism by 
which the peptides induce this behavior may involve modulation of DPI kinase 
activity, presumably as a result of a reduction in the degree of phosphorylation of the 
B-50 proteinZ0, 22. The correspondence in structure activity studies suggests that the 
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effects of ACTH on B-50 phosphorylation and TPI formation on the one hand, and on 
excessive grooming behavior on the other, are correlated. More research should be 
performed to establish whether a causal relationship exists, to determine whether the 
neurochemical events indeed underly the physiological effects of ACTH. 
Further study is also needed to account for the effects of (D-PheT)ACTH4-10 and 
a-M SH. These peptides induce excessive grooming but lack effect on TPI/PA formation: 
(D-PheV)ACTH4_10 stimulated the formation of DPI, but not TPI, and a-MSH did not 
have any effect on the brain (poly)PI. There was also a marked discrepancy in the 
affinity of ACTHI-m and a-MSH ((Ac-Serl)ACTHl-13-NH2) 32 at the brain opiate 
receptor 11. 
The structural requirements for ACTH-effects on extinction of active avoidance 
behavior are well characterized and seem less exacting than those obtained for 
excessive grooming: affinity sites were in the regions (4-7), (7-10) and (10-16) 15 . The 
same seems to hold for the stimulation of DPI formation, which could be elicited by 
(4-10), (7-16), (5-14), (1-10), (D-Phe 7) (4-10), (D-Phe 7) (1-10) and by the two 
potentiated analogs of the sequences (4-9) and (4-16). So it is tempting to relate the 
effects on DPI formation to those on extinction of active avoidance behavior in vivo. 
Some of the CNS effects of ACTH may be caused by interaction with opiate 
receptors19, 34. Therefore, the inhibition of PA formation which is observed after 
ACTH1-24 and after the opioid peptide/3-endorphin may reflect the interaction with 
opiate receptors. Likewise, the sequence (7-16) which has the same affinity for brain 
opiate receptors as ACTH1-2411 is also a very potent inhibitor of PA formation (Table 
I). Anionic lipids are reported to be important for opiate receptor binding23, 24. 
Therefore, the effects found with {3-endorphin, ACTH7 16 and larger ACTH frag- 
ments may indicate that some parallel exists between opiate-like effects and effects on 
the metabolism of the polyanionic phosphoinositides. However, a close correlation 
between peptide effects on PA formation and opiate-like activity does not appear from 
the data, as the sequences (4-10), (1-10) and (5-14) have affinity for opiate receptors 31 
but have no effect on PA formation at the dose level tested (100 #M). 
In conclusion, the presently reported findings that different sites within the 
ACTH molecule are important or essential for different molecular effects, are 
consistent with the hypothesis 5 that there are multiple affinity sites within the sequence 
ACTH1-24, accounting for the diversity of ACTH-brain  cell interactions. The 
parallel between effects of ACTH and congeners on the metabolism of the phospho- 
inositides and other in vivo and in vitro parameters is of interest in view of the possible 
functional significance of these polyanionic membrane components (see 23). The 
polyphosphoinositide system seems to be involved in the gating of Ca 2÷ through the 
membrane26, zT. DPI and TPI bind Ca 2+ very avidly 3,z8 and the enzymes involved in 
their metabolism are among the fastest acting known TM,22. A function in the regulation 
of the membrane potential has been suggested 33, and they seem to be involved in the 
steroidogenic actions of ACTH in the adrenals6,7, 8. 
Although the presently reported findings suggest that the polyphosphoinositides 
could indeed play an important role in the regulation of membrane characteristics, and 
thereby of the activity of the neurone, one should be cautious in asserting functional 
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correlates to the peptide-induced changes in polyPI  metabolism. After all, the present 
research has only established a correlat ion between lipid changes measured in vitro, 
and  behavior  changes measured in vivo. Fur ther  research should make clear whether 
al terat ions in the polyPI  metabol ism in vivo could under ly  the behavioral  effects of the 
neuropeptides.  
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